MYC-targeting by OMO-103 in solid tumours: a phase 1 trial

A Phase I Dose-Escalation Study of a first-in-modality MYC inhibitor, OMO-103, in All-Comers Solid Tumors and identification of potential biomarkers

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Garralda, Elena, Beaulieu, Marie-Eve, Moreno, Victor, Martínez-Martín, Sandra, Foradada, Laia, Alonso, Guzman, Massó-Vallés, Daniel, López-Estévez, Sergio, Casacuberta-Serra, Sílvia, Jauset, Toni, Corral, Elena, Doger, Bernard, Hernández, Tatiana, Pérez-López, Raquel, Arqués, Oriol, Castillo Cano, Virginia, Morales, Josefa, Whitfield, Jonathan R., Niewel, Manuela, Soucek, Laura, Calvo, Emiliano
Format:	Dataset
Sprache:	eng
Schlagworte:	Biomarkers Cancer Therapy (excl. Chemotherapy and Radiation Therapy)
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A Phase I Dose-Escalation Study of a first-in-modality MYC inhibitor, OMO-103, in All-Comers Solid Tumors and identification of potential biomarkers
DOI:	10.6084/m9.figshare.24747630